Finance

Lists
Q3 2026 earnings • released • EPS beat +5,61% • Revenue beat +3,49%
See results
AVTR:NYSE
Avantor Inc
16,05 USD
-3,78%
(-0,63) 1D
15,86 USD
-1,20% (-0,19)
Pre-market
Closed: 30-окт., 15:00:11 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVTR...
Open
16,74 USD
High
16,80 USD
Low
15,85 USD
Mkt. cap
10,88 млд
Avg. vol.
10,18 млн
Volume
9,73 млн
P/E ratio
32,34
52-wk high
17,45 USD
52-wk low
7,26 USD
EPS
0,50 USD
Beta
0,94
Shares outstanding
677,62 млн
No. of employees
14 миң
Open
16,74 USD
High
16,80 USD
Low
15,85 USD
Mkt. cap
10,88 млд
Avg. vol.
10,18 млн
Volume
9,73 млн
P/E ratio
32,34
52-wk high
17,45 USD
52-wk low
7,26 USD
EPS
0,50 USD
Beta
0,94
Shares outstanding
677,62 млн
No. of employees
14 миң
News stories
From web sources and news partners
Profile
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”. Wikipedia
About Avantor Inc
CEO-
Employees13,5 миң
Founded1904
HeadquartersРаднор Тауншип, Пенсильвания, Америка Кошмо Штаттары
SectorHealth care
Analyst ratings
Based on 13 analysts giving stock ratings to AVTR in the past 3 months
Hold
Buy
1
Hold
11
Sell
1
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for AVTR in the last 3 months.
Highest
Current 16,05 USD
18,00 USD (+12,15%)
Average
16,63 USD (+3,61%)
Lowest
15,00 USD (-6,54%)
Analyst
Recommendation
Action
Price target
Projected
Date
Casey Woodring
J.P. Morgan
Hold
Maintained
17,00 USD
+5,9%
10/29/2026
Justin Bowers
Deutsche Bank
Hold
Maintained
17,00 USD
+5,9%
10/29/2026
Dan Leonard
RBC Capital
Hold
Reiterated
17,00 USD
+5,9%
10/28/2026
Daniel Arias
Stifel Nicolaus
Hold
Maintained
18,00 USD
+12,1%
10/29/2026
Luke Sergott
Barclays
Sell
Maintained
16,00 USD
-0,3%
10/29/2026
Vijay Kumar
Evercore ISI
Hold
Maintained
17,00 USD
+5,9%
10/28/2026
Robert Bamberger
Robert W. Baird
Buy
Maintained
17,00 USD
+5,9%
10/27/2026
Eve Burstein
Bernstein
Hold
Reiterated
15,50 USD
-3,4%
10/19/2026
Daniel Brennan
TD Cowen
Hold
Maintained
17,00 USD
+5,9%
10/13/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Reiterated
15,00 USD
-6,5%
10/13/2026
Lu Li
Bank of America Securities
Hold
Maintained
17,00 USD
+5,9%
10/09/2026
Unknown Analyst
Bank of America Securities
Hold
Maintained
17,00 USD
+5,9%
10/09/2026
Evan Stampler
Wells Fargo
Buy
Maintained
16,00 USD
-0,3%
09/21/2026
Matt Larew
William Blair
Hold
Reiterated
-
-
09/21/2026
Unknown Analyst
UBS
Hold
Initiated
16,00 USD
-0,3%
09/08/2026
Doug Schenkel
UBS
Hold
Maintained
16,00 USD
-0,3%
09/09/2026
Brandon Couillard
Wells Fargo
Buy
Maintained
16,00 USD
-0,3%
07/30/2026
Tycho Peterson
Jefferies
Hold
Upgraded
13,00 USD
-19%
07/29/2026
Patrick B Donnelly
Citi
Hold
Maintained
11,00 USD
-31,5%
07/08/2026
Michael Polark
Wolfe Research
Sell
Reiterated
7,00 USD
-56,4%
06/01/2026
Unknown Analyst
RBC Capital
Hold
Initiated
9,00 USD
-43,9%
05/14/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
11,00 USD
-31,5%
02/12/2026
Michael Ryskin
Bank of America Securities
Hold
Reiterated
11,00 USD
-31,5%
02/11/2026
Last report
2026-ж., 28-окт.
Fiscal period
Q3 2026
0,22 USD / 0,21 USD
+5,61%beat
Revenue / Est. (USD)
1,70 млд / 1,64 млд
+3,49%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
1,66 млд
1,58 млд
1,69 млд
1,70 млд
Cost of goods sold
1,14 млд
1,08 млд
1,16 млд
1,16 млд
Cost of revenue
1,14 млд
1,08 млд
1,16 млд
1,16 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
354,70 млн
401,70 млн
415,80 млн
395,80 млн
Operating expense
354,70 млн
401,70 млн
415,80 млн
395,80 млн
Total operating expenses
1,49 млд
1,48 млд
1,57 млд
1,56 млд
Operating income
169,20 млн
99,00 млн
121,20 млн
139,00 млн
Other non operating income
-7,00 млн
-
100,00 миң
-
EBT including unusual items
80,80 млн
55,50 млн
81,20 млн
98,00 млн
EBT excluding unusual items
120,10 млн
56,10 млн
81,80 млн
98,80 млн
Income tax expense
28,40 млн
12,20 млн
43,10 млн
-105,40 млн
Effective tax rate
35,15%
21,98%
53,08%
-107,55%
Other operating expenses
-
-
-
-
Net income
52,40 млн
43,30 млн
38,10 млн
203,40 млн
Net profit margin
3,15%
2,74%
2,25%
11,98%
Earnings per share
0,22
0,17
0,21
0,22
Interest and investment income
11,40 млн
10,50 млн
10,30 млн
10,20 млн
Interest expense
-53,40 млн
-53,40 млн
-49,70 млн
-51,80 млн
Net interest expenses
-42,00 млн
-42,90 млн
-39,40 млн
-41,60 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
272,50 млн
204,00 млн
226,80 млн
244,30 млн
Gain or loss from assets sale
5,10 млн
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору